103 related articles for article (PubMed ID: 2567285)
1. The EcoRI RFLP of c-mos in patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non-geriatric controls.
Chenevix-Trench G; Southall M; Kidson C
Int J Cancer; 1989 Jun; 43(6):1034-6. PubMed ID: 2567285
[TBL] [Abstract][Full Text] [Related]
2. Allelic variation of the c-raf-1 proto-oncogene in human lymphoma and leukemia.
Trench GC; Southall M; Smith P; Kidson C
Oncogene; 1989 Apr; 4(4):507-10. PubMed ID: 2566145
[TBL] [Abstract][Full Text] [Related]
3. Evidence against a tumour-specific EcoRI RFLP of the c-mos locus.
Corell B; Zoll B
FEBS Lett; 1988 Mar; 230(1-2):81-4. PubMed ID: 2895024
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.
Crossen PE; Morrison MJ; Colls BM
Br J Cancer; 1994 Apr; 69(4):759-61. PubMed ID: 7908219
[TBL] [Abstract][Full Text] [Related]
5. Elevated frequency of a SstI polymorphism of the Ets-1 oncogene in non-Hodgkin's lymphoma patients.
Crossen PE; Morrison MJ; Colls BM
Cancer Genet Cytogenet; 1995 Jan; 79(1):70-3. PubMed ID: 7850755
[TBL] [Abstract][Full Text] [Related]
6. Restriction fragment length polymorphisms in the ETS-1 proto-oncogene. Comparison of Saudi and Western populations.
Parkar MH; Seid JM; Rowson JM; Stringer BM; Vencer LJ; Aur RJ; Goyns MH
Experientia; 1988 Dec; 44(11-12):1019-20. PubMed ID: 2461869
[TBL] [Abstract][Full Text] [Related]
7. Restriction fragment length polymorphisms of L-myc and myb in human leukaemia and lymphoma in relation to age-selected controls.
Chenevix-Trench G; Southall M; Kidson C
Br J Cancer; 1989 Dec; 60(6):872-4. PubMed ID: 2574989
[No Abstract] [Full Text] [Related]
8. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
Dolcetti R; Pelucchi S; Maestro R; Rizzo S; Pastore A; Boiocchi M
Eur Arch Otorhinolaryngol; 1991; 248(5):279-85. PubMed ID: 1679639
[TBL] [Abstract][Full Text] [Related]
9. Fine-needle aspiration of non-Hodgkin's lymphoma. Southern blot analysis for antigen receptor, bcl-2, and c-myc gene rearrangements.
Williams ME; Frierson HF; Tabbarah S; Ennis PS
Am J Clin Pathol; 1990 Jun; 93(6):754-9. PubMed ID: 2189291
[TBL] [Abstract][Full Text] [Related]
10. Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients.
Lidereau R; Mathieu-Mahul D; Theillet C; Renaud M; Mauchauffé M; Gest J; Larsen CJ
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7068-70. PubMed ID: 2996003
[TBL] [Abstract][Full Text] [Related]
11. Allelic variation of the c-raf-1 oncogene in non-Hodgkin's lymphoma.
Chenevix-Trench G; Behm F; Westin E
Leukemia; 1987 Jan; 1(1):82-6. PubMed ID: 2889852
[TBL] [Abstract][Full Text] [Related]
12. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults.
Gemmati D; Ongaro A; Scapoli GL; Della Porta M; Tognazzo S; Serino ML; Di Bona E; Rodeghiero F; Gilli G; Reverberi R; Caruso A; Pasello M; Pellati A; De Mattei M
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):787-94. PubMed ID: 15159311
[TBL] [Abstract][Full Text] [Related]
13. Restriction fragment length polymorphism of the L-myc oncogene in non-Hodgkin's lymphoma patients from India.
Fernandez T; Saranath D; Advani SH; Deo MG; Soman CS
Cancer Lett; 1998 Mar; 125(1-2):165-9. PubMed ID: 9566711
[TBL] [Abstract][Full Text] [Related]
14. Association between EcoRI fragment-length polymorphism of the immunoglobulin lambda variable 8 (IGLV8) gene family with rheumatoid arthritis and systemic lupus erythematosus.
Queiroz RG; Tamia-Ferreira MC; Carvalho IF; Petean FC; Passos GA
Braz J Med Biol Res; 2001 Apr; 34(4):525-8. PubMed ID: 11285465
[TBL] [Abstract][Full Text] [Related]
15. A single point mutation responsible for c-mos polymorphism in cancer patients.
Lidereau R; Cole ST; Larsen CJ; Mathieu-Mahul D
Oncogene; 1987 May; 1(2):235-7. PubMed ID: 2894001
[TBL] [Abstract][Full Text] [Related]
16. An EcoRI restriction fragment length polymorphism (RFLP) in the human c-erb A locus.
Mathieu-Mahul D; Xu DQ; Saule S; Lidereau R; Galibert F; Berger R; Mauchauffé M; Larsen CJ
Hum Genet; 1985; 71(1):41-4. PubMed ID: 2993156
[TBL] [Abstract][Full Text] [Related]
17. Presence of an EcoRI RFLP of the c-mos locus in normal and tumor tissue of esophageal cancer patients.
Hollstein M; Montesano R; Yamasaki H
Nucleic Acids Res; 1986 Nov; 14(21):8695. PubMed ID: 2878411
[No Abstract] [Full Text] [Related]
18. Genomic EcoRI polymorphism and cosmid sequencing reveal an insertion/deletion and a new IGLV5 allele in the human immunoglobulin lambda variable locus (22q11.2/IGLV).
Moraes Junta C; Passos GA
Immunogenetics; 2003 Apr; 55(1):10-5. PubMed ID: 12679855
[TBL] [Abstract][Full Text] [Related]
19. RFLP of the human c-fes proto-oncogene.
Tesch H; Olek K; Geisel J; Van de Ven WJ; Jücker M
Nucleic Acids Res; 1988 May; 16(9):4193. PubMed ID: 2897677
[No Abstract] [Full Text] [Related]
20. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
